Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Baudax Bio, Inc. (BXRX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 9,000,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Baudax Bio is a pharmaceutical company primarily focused on commercializing and developing products for hospital and related acute care settings. Co. has launched its commercial product, ANJESO in the U.S. ANJESO is an intravenous analgesic agent. ANJESO is a cyclooxygenase-2 preferential, non-steroidal anti-inflammatory, or NSAID for the management of moderate to severe pain, which can be administered alone or in combination with other non-NSAID analgesics. Co.'s pipeline also includes other earlier stage product candidates including intermediate and short-acting neuromuscular blocking agents, and accompanying reversal agents that Co. is developing for use in hospital or related settings.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,200
Total Buy Value $0 $0 $0 $3,057
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 56
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Weisman Wayne Director   –       •      –    2019-12-05 4 A $0.00 $0 D/D 20,000 30,582     -
   Ashton William Director   –       •      –    2019-12-05 4 A $0.00 $0 D/D 20,000 27,782     -
   Henwood Geraldine President and CEO   •       •      –    2019-12-05 4 A $0.00 $0 D/D 323,958 353,868     -
   Recro Pharma, Inc. 10% Owner   –       –       •   2019-11-21 4 D $0.00 $0 D/D (9,211,245) 0     -
   Recro Pharma, Inc. 10% Owner   –       –       •   2019-11-21 4 A $0.00 $0 D/D 9,211,145 9,211,245     -
   Recro Pharma, Inc. 10% Owner   –       –       •   2019-11-12 3 IO $0.00 $0 D/D 0 100     -

  56 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed